ARCHIMED
ARCHIMED is a Series C+ and buyout fund in global writing $10M–$1B checks into Healthcare.
- Stages
- Series C+, buyout
- Sectors
- Healthcare
- Check size
- $10M–$1B
- Invests in
- global
Thesis
ARCHIMED is a private equity firm specializing in the healthcare sector, with a focus on small to midsize companies. They invest globally, with a significant presence in Europe and North America. ARCHIMED also emphasizes impact investing, aligning with sustainable development goals and supporting charitable initiatives within healthcare. Their investment approach is data-driven, utilizing proprietary tools for market segmentation and deal sourcing. They invest across seven key healthcare sectors: Life Science Tools & Services, Biopharma Products, Diagnostics, MedTech, Healthcare IT, Consumer Health, and Animal & Environmental Health. Investments typically range from €10 million to €1 billion.
Common questions
Does ARCHIMED invest at the Series C+ stage?
Yes. ARCHIMED lists Series C+ and buyout among the stages it invests in.
What check size does ARCHIMED write?
ARCHIMED writes $10M–$1B checks.
Where does ARCHIMED invest?
ARCHIMED invests in global.